{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T18:43:06Z","timestamp":1765478586704,"version":"3.48.0"},"reference-count":16,"publisher":"BMJ","issue":"6658","license":[{"start":{"date-parts":[[1988,11,12]],"date-time":"1988-11-12T00:00:00Z","timestamp":595296000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1988,11,12]]},"DOI":"10.1136\/bmj.297.6658.1213","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T15:19:55Z","timestamp":1238685595000},"page":"1213-1214","source":"Crossref","is-referenced-by-count":3,"title":["Controlling the carcinoid syndrome."],"prefix":"10.1136","volume":"297","author":[{"given":"H. J.","family":"Hodgson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1988,11,12]]},"reference":[{"key":"ref_1","first-page":"1519","article-title":"Whole abdominal irradiation in the management of metastatic gastrointestinal carcinoid tumour. Intu Radiat Oncol Biol","volume":"7","author":"Keane, T.S.; Rider, W.S.; Harwood, H.R.","year":"1981","unstructured":"Keane TS, Rider WS, Harwood HR. Whole abdominal irradiation in the management of metastatic gastrointestinal carcinoid tumour. Intu Radiat Oncol Biol Phys 1981;7:1519-21.","journal-title":"Phys"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1148\/radiology.164.1.3588904","article-title":"Carcinoid tumours, CT and 3Il-metaiodobenzylguanidine scintigraphy","volume":"164","author":"Kimming, B.N.; Georgi, P.; Adolph, J.M.G.; Zum Winkel, K.","year":"1987","unstructured":"Kimming BN, Georgi P, Adolph JMG, Zum Winkel K. Carcinoid tumours, CT and 3Il-metaiodobenzylguanidine scintigraphy. Radiology 1987;164: 199-203.","journal-title":"Radiology"},{"key":"ref_3","first-page":"166","article-title":"Surgical management of carcinoid syndrome","volume":"35","author":"Galland, R.B.; Blumgart, L.H.","year":"1986","unstructured":"Galland RB, Blumgart LH. Surgical management of carcinoid syndrome. Br J Hosp Med 1986;35: 166-70.","journal-title":"Br J Hosp Med"},{"key":"ref_4","first-page":"444","article-title":"Treatment of the carcinoid syndrome by local removal of hepatic metastases","volume":"65","author":"Stephen, J.L.; Graeme-Smith, D.G.","year":"1972","unstructured":"Stephen JL, Graeme-Smith DG. Treatment of the carcinoid syndrome by local removal of hepatic metastases. Proceedings ofthe Royal Society ofMedicine 1972;65:444-5.","journal-title":"Proceedings ofthe Royal Society ofMedicine"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0002-9343(86)90584-X","article-title":"Metastatic carcinoid tumours and the carcinoid syndrome","volume":"81","author":"Kvols, L.K.","year":"1986","unstructured":"Kvols LK. Metastatic carcinoid tumours and the carcinoid syndrome. AmJ Med 1986;81:49-55.","journal-title":"AmJ Med"},{"key":"ref_6","first-page":"1297","article-title":"Treatment of malignant carcinoid tumours with human leucocyte interferon. Long-term results","volume":"70","author":"Oberg, K.; Norheim, I.; Lind, E.","year":"1986","unstructured":"Oberg K, Norheim I, Lind E, et al. Treatment of malignant carcinoid tumours with human leucocyte interferon. Long-term results. Cancer Treat Rep 1986;70:1297-304.","journal-title":"Cancer Treat Rep"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000395682","article-title":"Present experiences with hepatic dearterialization in liver neoplasm","volume":"13","author":"Bengmark, S.; Fredlund, P.; Hafstrom, L.; Vang, J.","year":"1974","unstructured":"Bengmark S, Fredlund P, Hafstrom L, Vang J. Present experiences with hepatic dearterialization in liver neoplasm. Progress in Surgery 1974;13:141.","journal-title":"Progress in Surgery"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(77)90369-5","article-title":"Treatment of carcinoid liver metastases by hepatic artery embolization","volume":"ii:","author":"Allison, D.J.; Modlin, I.M.; Jenkins, W.J.","year":"1977","unstructured":"Allison DJ, Modlin IM, Jenkins WJ. Treatment of carcinoid liver metastases by hepatic artery embolization. Lancet 1977;ii:1323-5.","journal-title":"Lancet"},{"key":"ref_9","first-page":"932","article-title":"Role ofhepatic artery embolisation in the carcinoid syndrome","volume":"287","author":"Maton, P.N.; Camilleri, M.; Griffin, G.; Allison, D.J.; Hodgson, H.J.F.; Chadwick, V.S.","year":"1983","unstructured":"Maton PN, Camilleri M, Griffin G, Allison DJ, Hodgson HJF, Chadwick VS. Role ofhepatic artery embolisation in the carcinoid syndrome. BrMedJ 1983;287:932-5.","journal-title":"BrMedJ"},{"key":"ref_10","first-page":"1329","article-title":"Effect of hepatic artery embolisation on survival in carcinoid syndrome","volume":"28","author":"Coupe, M.; Hemmingway, A.; Hodgson, H.J.F.; Allison, D.J.","year":"1987","unstructured":"Coupe M, Hemmingway A, Hodgson HJF, Allison DJ. Effect of hepatic artery embolisation on survival in carcinoid syndrome. Gut 1987;28:A1329.","journal-title":"Gut"},{"key":"ref_11","first-page":"35","article-title":"Carcinoid and neuroendocrine tumours. Baillieres Clin Gasroenterol","volume":"1","author":"Hodgson, H.J.F.; Maton, P.N.","year":"1987","unstructured":"Hodgson HJF, Maton PN. Carcinoid and neuroendocrine tumours. Baillieres Clin Gasroenterol 1987;1:35-61."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0028-3908(86)90207-8","article-title":"Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamines","volume":"25","author":"Bradley, P.B.; Engel, G.; Feniuk, W.","year":"1986","unstructured":"Bradley PB, Engel G, Feniuk W, et al. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamines. NeuropharmacoloV 1986;25:563-76.","journal-title":"NeuropharmacoloV"},{"issue":"65","key":"ref_13","first-page":"941","article-title":"Studies on several possible antiserotonin agents in a patient with the functioning carcinoid syndrome","volume":"1962","author":"Vroom, F.Q.; Brown, R.E.; Dempsey, H.; Hill, SR","unstructured":"Vroom FQ, Brown RE, Dempsey H, Hill SR. Studies on several possible antiserotonin agents in a patient with the functioning carcinoid syndrome. Ann Intern Med 1962;65:941-5.","journal-title":"Ann Intern Med"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3109\/00365528609011123","article-title":"Ketanserin versus placebo in carcinoid syndrome","volume":"21","author":"Gustafsen, J.; Lendorf, A.; Raskov, H.; Boesby, S.","year":"1986","unstructured":"Gustafsen J, Lendorf A, Raskov H, Boesby S. Ketanserin versus placebo in carcinoid syndrome. ScandJ Gasoenterol 1986;21:816-8.","journal-title":"ScandJ Gasoenterol"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2036.1988.tb00684.x","article-title":"The effects of the 5-hydroxytryptamine (5HT3) receptor antagonist ICS 205-930 in the carcinoid syndrome","volume":"2","author":"Coupe, M.O.; Anderson, J.V.; Morris, J.A.; Alstead, E.M.; Bloom, SR, Hodgson; H.J.F.","year":"1988","unstructured":"Coupe MO, Anderson JV, Morris JA, Alstead EM, Bloom SR, Hodgson HJF. The effects of the 5-hydroxytryptamine (5HT3) receptor antagonist ICS 205-930 in the carcinoid syndrome. Alimentry Pharmacology and Therapeutics 1988;2:167-72.","journal-title":"Alimentry Pharmacology and Therapeutics"},{"key":"ref_16","first-page":"633","article-title":"Treatment of the malignant carcinoid syndrome: evaluation of a long-acting somatostatin analogue","volume":"315","author":"Kvols, L.K.; Moertel, C.G.; O'Connell, M.J.; Schute, A.J.; Rudin, J.; Hahn, R.G.","year":"1986","unstructured":"Kvols LK, Moertel CG, O'Connell MJ, Schute AJ, Rudin J, Hahn RG. Treatment of the malignant carcinoid syndrome: evaluation of a long-acting somatostatin analogue. N Engl J Med 1986;315:633-6.","journal-title":"N Engl J Med"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.297.6658.1213","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.297.6658.1213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T18:39:33Z","timestamp":1765478373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.297.6658.1213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,11,12]]},"references-count":16,"journal-issue":{"issue":"6658","published-online":{"date-parts":[[1988,11,12]]},"published-print":{"date-parts":[[1988,11,12]]}},"alternative-id":["10.1136\/bmj.297.6658.1213"],"URL":"https:\/\/doi.org\/10.1136\/bmj.297.6658.1213","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"type":"print","value":"0959-8138"},{"type":"electronic","value":"1468-5833"}],"subject":[],"published":{"date-parts":[[1988,11,12]]}}}